Aeglea Biotherapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.5M | 330k | 16.76 |
| 2025-03-31 | $3.2M | 197k | 16.14 |
| 2024-12-31 | $17M | 748k | 23.28 |
| 2024-09-30 | $5.0M | 169k | 29.41 |
| 2024-06-30 | $21M | 893k | 23.51 |
| 2024-03-31 | $9.1M | 240k | 37.93 |